Wire Stories

Category Added in a WPeMatico Campaign

news_6

BeiGene Announces Acceptance of Supplemental New Drug Application in China for BRUKINSA (zanubrutinib) in Chronic Lymphocytic Leukemia with Breakthrough Therapy Designation

BRUKINSA was granted its first breakthrough therapy designation in China with this application The application is supported by SEQUOIA trial...

news_6

Hypogonadism Market Spotlight Report 2021: Clinical Trials, Regulatory Events, Licensing and Acquisitions, and Drug-specific Revenue Forecasts – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Market Spotlight: Hypogonadism" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the Hypogonadism market,...